Cholesterol reduction following health screening in general practice

被引:11
作者
Kanstrup, H
Refsgaard, J
Engberg, M
Lassen, JF
Larsen, ML
Lauritzen, T
机构
[1] Aarhus Univ, Dept Gen Practice, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Aarhus Kommune Hosp, Dept Internal Med & Cardiol, Aarhus, Denmark
关键词
health checks; Ebeltoft project; lipid lowering; cholesterol; middle-aged; adult;
D O I
10.1080/028134302321004872
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives - To evaluate changes in plasma cholesterol following health screening and health discussions in general practice. Design - Randomised prospective population-base d study conducted over a period of 5 years. Setting - Primary care, all general practitioners (GPs) in a well-defined area. Subjects - A random sample of inhabitants aged 30-49 years in January 1991, registered with a local GP was invited to participate. The participants (1507 persons, or 75.4% of the 2000 invited) were randomly allocated to two intervention groups and a control group. Main outcome measures - Plasma cholesterol, percentage of subjects with plasma cholesterol higher than 7 mmol/l. Results - After 5 years of intervention, plasma cholesterol in the whole population was significantly lower in the intervention groups compared to the control group. The decrease was most pronounced (0.5 mmol/l) in subjects at high cardiovascular risk. The percentage of high-risk individuals with a cholesterol level higher than 7 mmol/l was significantly lower in the intervention groups compared to the control group (9.8% vs 6.2%, p = 0.04), corresponding to a 37% reduction. Conclusions - The study shows that the health checks had a measurable impact on plasma cholesterol levels, the most pronounced effect is seen among individuals at high cardiovascular risk.
引用
收藏
页码:219 / 223
页数:5
相关论文
共 11 条
[1]   PREVENTION OF CARDIOVASCULAR-DISEASE IN GENERAL-PRACTICE - A PROPOSED MODEL [J].
ANGGARD, EE ;
LAND, JM ;
LENIHAN, CJ ;
PACKARD, CJ ;
PERCY, MJ ;
RITCHIE, LD ;
SHEPHERD, J .
BRITISH MEDICAL JOURNAL, 1986, 293 (6540) :177-180
[2]  
[Anonymous], 1994, BMJ, V308, P313
[3]  
COULTER A, 1995, BRIT MED J, V310, P1099
[4]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[5]   Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease [J].
Ebrahim, S ;
Smith, GD .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7095) :1666-1674
[6]   Health checks and coronary risk: Further evidence from a randomised controlled trial [J].
Hanlon, P ;
McEwen, J ;
Carey, L ;
Gilmour, H ;
Tannahill, C ;
Tannahill, A ;
Kelly, M .
BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7020) :1609-1613
[7]  
Int Task Force Prevent Coron Heart Dis, 1998, NUTR METAB CARDIOVAS, V8, P205
[8]  
LAURITZEN T, 1995, BRIT J GEN PRACT, V45, P542
[9]  
PEDERSEN TR, 1994, LANCET, V344, P1383
[10]   PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].
SHEPHERD, J ;
COBBE, SM ;
FORD, I ;
ISLES, CG ;
LORIMER, AR ;
MACFARLANE, PW ;
MCKILLOP, JH ;
PACKARD, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307